Intraoperative direct hemoperfusion with a polymyxin-B immobilized fiber column for treatment of infective endocarditis

General Thoracic and Cardiovascular Surgery

Volumn 59, Issue 2, 2011, Pages 98-104

  Totsugawa, Toshinori ^a   Kuinose, Masahiko ^a   Yoshitaka, Hidenori ^a   Tsushima, Yoshimasa ^a   Ishida, Atsuhisa ^a   Chikazawa, Genta ^a   Katayama, Keijiro ^a   Hiraoka, Arudo ^a  

^a THE SAKAKIBARA HEART INSTITUTE OF OKAYAMA   (Japan)

Author keywords

Direct hemoperfusion; Endotoxin adsorption; Infective endocarditis; Polymyxin b immobilized fi ber column

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CATECHOLAMINE; POLYMYXIN B;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIUM ISOLATION; BLOOD FLOW VELOCITY; CANDIDA; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE REDUCTION; FEMALE; HEART LEFT VENTRICLE FAILURE; HEMOPERFUSION; HUMAN; INTRAOPERATIVE PERIOD; LENGTH OF STAY; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; POSTOPERATIVE PERIOD; PROSTHETIC VALVE ENDOCARDITIS; PROTEIN BLOOD LEVEL; RENAL REPLACEMENT THERAPY; STAPHYLOCOCCUS; STREPTOCOCCUS; TURBIDIMETRY;

ADULT; AGED; CARDIAC SURGICAL PROCEDURES; CARDIOTONIC AGENTS; CATECHOLAMINES; COMBINED MODALITY THERAPY; CRITICAL ILLNESS; ENDOCARDITIS; ENDOTOXINS; FEMALE; HEMOPERFUSION; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE; INTRAOPERATIVE CARE; JAPAN; LENGTH OF STAY; MALE; MIDDLE AGED; POLYMYXIN B; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 79954439518     PISSN: 18636705     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11748-010-0700-1     Document Type: Article

References (24)

1. Aoki H, Kodama M, Tani T, Hanasawa K. Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber. Am J Surg 1994;167:412-7.
2. Vincent JL, Laterre PF, Cohen J, Burchardi H, Bruining H, Lerma FA, et al. A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection. Shock 2005;23:400-5. (Pubitemid 40571661)
3. Cruz DN, Perazella MA, Bellomo R, de Cal M, Polanco N, Corradi V, et al. Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review. Crit Care 2007;11:R47.
4. Cruz DN, Antonelli M, Fumagalli R, Foltran F, Brienza N, Donati A, et al. Early use of polymyxin B hemoperfusion in abdominal septic shock: the EUPHAS randomized controlled trial. JAMA 2009;301:2445-52.
5. Murakami M, Miyauchi Y, Nishida M, Okada H, Hamano K. Direct hemoperfusion using polymyxin-B immobilized fiber for septic shock after cardiac surgery. Circ J 2009;73:658-61.
6. Asano M, Hanafusa Y, Otake H, Kazuma H. PMX-DHP therapy for a patient with infectious endocarditis. Jpn J Crit Care Endotoxemia 2005;9:247-50 (in Japanese with English abstract).
7. Totsugawa T, Kuinose M, Yoshitaka H, Ishii S, Tsushima Y, Ishida A. Intraoperative endotoxin adsorption as a new therapeutic option for mycotic aortic aneurysm. Circ J 2008;72: 161-3. (Pubitemid 351413346)
8. Totsugawa T, Ozawa M, Kuinose M, Ishii S, Yoshitaka H, Tamaki T. Intraoperative endotoxin adsorption for visceral malperfusion complicating acute type A aortic dissection. Gen Thorac Cardiovasc Surg 2010;58:134-7.
9. Nakatani S, Mitsutake K, Hozumi T, Yoshikawa J, Akiyama M, Yoshida K, et al. Current characteristics of infective endocarditis in Japan: an analysis of 848 cases in 2000 and 2001. Circ J 2003;67:901-5. (Pubitemid 37370237)
10. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients with Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008;118:e523-661.
11. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure: on behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996;22:707-10.
12. Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation 2007;116: 1736-54.
13. Murphy GJ, Angelini GD. Side effects of cardiopulmonary bypass: what is the reality? J Card Surg 2004;19:481-8. (Pubitemid 39587405)
14. Aydin NB, Gercekoglu H, Aksu B, Ozkul V, Sener T, Kiygil I, et al. Endotoxemia in coronary artery bypass surgery: a comparison of the off-pump technique and conventional cardiopulmonary bypass. J Thorac Cardiovasc Surg 2003;125: 843-8. (Pubitemid 36457505)
15. Rothenburger M, Soeparwata R, Deng MC, Berendes E, Schmid C, Tjan TD, et al. The impact of anti-endotoxin core antibodies on endotoxin and cytokine release and ventilation time after cardiac surgery. J Am Coll Cardiol 2001;38:124-30. (Pubitemid 32613838)
16. Mythen MG, Webb AR. The role of gut mucosal hypoperfusion in the pathogenesis of post-operative organ dysfunction. Intensive Care Med 1994;20:203-9. (Pubitemid 24088584)
17. Caty MG, Guice KS, Oldham KT, Remick DG, Kunkel SI. Evidence for tumor necrosis factor-induced pulmonary microvascular injury after intestinal ischemia-reperfusion injury. Ann Surg 1990;212:694-700.
18. Ohki S, Oshima K, Takeyoshi I, Matsumoto K, Morishita Y. Endotoxin removal with a polymyxin B-immobilized hemoperfusion cartridge improves cardiopulmonary function after cardiopulmonary bypass. J Surg Res 2008;145:74-9. (Pubitemid 351221096)
19. Iwama H, Komatsu T. Effect of an endotoxin-removing column containing immobilized polymyxin B fiber in a patient with septic shock from gram-positive infection. Acta Anaesthesiol Scand 1998;42:590-3. (Pubitemid 28218484)
20. Gao JJ, Xue Q, Papasian CJ, Morrison DC. Bacterial DNA and lipopolysaccharide induce synergistic production of TNFalpha through a post-transcriptional mechanism. J Immunol 2001;166:6855-60. (Pubitemid 32467231)
21. Ruud TE, Gundersen Y, Wang JE, Foster SJ, Thiemermann C, Aasen AO. Activation of cytokine synthesis by systemic infusions of lipopolysaccharide and peptidoglycan in a porcine model in vivo and in vitro. Surg Infect (Larchmt) 2007;8: 495-503. (Pubitemid 350114702)
22. Wang Y, Liu Y, Sarker KP, Nakashima M, Serizawa T, Kishida A, et al. Polymyxin B binds to anandamide and inhibits its cytotoxic effect. FEBS Lett 2000;470:151-5. (Pubitemid 30151087)
23. Kushi H, Miki T, Nakahara J, Okamoto K, Saito T, Tanjoh K. Hemoperfusion with an immobilized polymyxin B column reduces the blood level of neutrophil elastase. Blood Purif 2006;24:212-7. (Pubitemid 43259176)
24. Sakamoto Y, Mashiko K, Matsumoto H, Hara Y, Kutsukata N, Yamamoto Y. Relationship between effect of polymyxin B-immobilized fiber and high-mobility group box-1 protein in septic shock patients. ASAIO J 2007;53:324-8.